WCWeiqi Chen

Weiqi Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Weiqi Chen has a total of 87 co-authors. Here are the top co-authors by number of shared publications:

  • Dingguo Huang

    Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong, Shantou, Guangdong, China

    13 shared publications
  • Dezhi Zheng

    Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, China

    12 shared publications
  • Zijing Huang

    Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, China

    9 shared publications
  • Yifan Wang

    Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, China

    8 shared publications
  • Guihua Zhang

    Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, China

    7 shared publications
  • Zijing Huang

    Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, China

    7 shared publications

Latest Publications

  • Regional and Temporal Changes in Choroidal Vascularity after Panretinal Photocoagulation in Diabetic Retinopathy: A Widefield SS-OCTA Study

    by Dingguo Huang, Lanxin Ren, Laiwen Lv, Jingsheng Yi, Zijing Huang, Weiqi Chen

    Purpose: To investigate the changes in choroidal vasculature after panretinal photocoagulation (PRP) in patients with proliferative diabetic retinopathy (PDR) using widefield swept-source optical coherence tomography angiography (SS-OCTA). Methods: Thirty eyes of 30 PDR patients were enrolled and underwent SS-OCTA examination before PRP, and at 1 month and 3 months after PRP. Twenty-two age-matched healthy volunteers served as controls. Choroidal thickness (ChT), choroidal vascular volume (CVV), choroidal vascularity index (CVI), choroidal stromal volume (CSV), choriocapillaris flow deficit percentage (CC FD%), and central macular thickness (CMT) were automatically measured within concentric rings of 2.5, 5, 12, and 19 mm centered on the fovea. Results: Post-PRP choroidal changes showed distinct regional specificity and time dependence. In the periphery (12–19 mm): CVV decreased (-5.45% at 1 month, P =0.045; -8.23% at 3 months, P P P =0.011); CSV remained unchanged. In the central region (0–2.5 mm): except for a mild decrease in CVV at 3 months (-4.01%, P =0.009), all other parameters showed no significant changes. CMT progressively increased (+ 7.49 7.50% at 1 month, +12.32% at 3 months, both P P =0.002) Exploratory regression analysis showed that baseline CMT and central ΔCVV were independently associated with ΔCMT (β=0.352, P =0.041; B=528.414, P =0.002, respectively). Conclusion: PRP induces “vessel-first atrophy” in the periphery with relative central preservation, supporting hemodynamic redistribution. Widefield SS-OCTA effectively evaluates post-PRP choroidal changes. The association between central choroidal vascular volume change and macular edema requires further investigation.

  • Choroidal vascularity profiles in diabetic macular oedema subtypes: a swept-source OCT angiography study

    by Lanxin Ren, Jingsheng Yi, Yifan Wang, Dezhi Zheng, Zijing Huang, Weiqi Chen, Dingguo Huang

    To characterise choroidal microvascular changes in diabetic macular oedema (DMO) subtypes using swept-source optical coherence tomography angiography (SS-OCTA). This cross-sectional study analysed 182 eyes with centre-involved DMO from 141 patients (45 diffuse retinal thickening [DRT], 72 cystoid macular oedema [CMO], 65 serous retinal detachment [SRD]) and 40 age-matched healthy controls. Imaging was performed using the VG200 SS-OCTA system with a 1050 nm wavelength and 200,000 A-scans/second scan speed. Parameters including choroidal thickness (ChT), choroidal volume (CV), choroidal vascularity index (CVI), and choriocapillaris flow deficit percentage (CC FD%) were assessed in three macular annular regions (1-, 3-, and 6-mm diameter rings cantered on the fovea). Compared to controls, all DMO subtypes exhibited choroidal microvascular dysfunction, including reduced CVI and increased ChT. Notably, SRD demonstrated the most severe flow deficits, with significantly larger CC FD% than both DRT (17.08 ± 10.83% vs 11.08 ± 7.38%, p = 0.002) and CMO (17.08 ± 10.83% vs 12.71 ± 8.16%, p = 0.014) in the 1-mm diameter ring. Similar differences were observed in the 3-mm diameter ring (SRD 12.66 ± 5.73% vs DRT 9.09 ± 5.00%, p = 0.002; SRD vs CMO 9.84 ± 5.11%, p = 0.007) and 6-mm diameter ring (SRD 9.87 ± 4.03% vs DRT 8.11 ± 4.40%, p = 0.003; SRD vs CMO 8.28 ± 4.07%, p = 0.026). No significant inter-subtype differences were found in CVI or ChT (p > 0.05). Choroidal microvascular dysfunction is present in all DMO subtypes, with SRD exhibiting the most severe choriocapillaris flow deficits. These findings suggest potential subtype-specific pathophysiological associations.

  • Intraoperative pain assessment using a digital force gauge during vitreoretinal surgery: a prospective feasibility study

    by De-Zhi Zheng, Wei-Qi Chen, Zi-Jing Huang, Ding-Guo Huang, Pei-Min Lin

    Purpose This study aimed to evaluate the feasibility of real-time intraoperative pain assessment using a digital force gauge during vitreoretinal surgery under sub-Tenon’s anesthesia. Methods In this prospective observational study, 63 patients undergoing vitreoretinal surgery under sub-Tenon’s anesthesia were enrolled between April and August 2023. The participants were asked to constantly compress a digital force gauge during the operation. The magnitude of the compressive force was directly proportional to the severity of pain they experienced. A Pain Index (PI) was derived from peak compressive force measurements to evaluate the intraoperative pain intensity. Immediately after the surgery, patients reported their intraoperative pain score and anxiety score using the Numerical Rating Scale (NRS). Concordance between PI and pain scores was analyzed using the intraclass correlation coefficient (ICC) and Kendall’s tau-b analysis. Results The PI was slightly higher than the patient-reported pain scores (1.37 ± 1.27 vs. 1.05 ± 1.28, P = 0.01). Complete consistency in values was observed in 33 cases (52.38%). Strong concordance emerged between PI and pain score (ICC = 0.75, 95% CI: 0.62–0.84; P < 0.01), along with a significant rank-order correlation (τ = 0.66, P < 0.01). Moreover, the PI showed a weaker correlation with anxiety score (τ = 0.32, P = 0.02) compared to pain score (τ = 0.51, P < 0.01). Conclusion The PI demonstrated favorable consistency and correlation with the conventional NRS for pain evaluation.

  • Epiretinal membrane formation following laser photocoagulation for peripheral retinal degeneration: incidence and risk factors

    by Biyao Xie, Yingjia Lin, Chiyu Lin, Xuna Qiu, Dezhi Zheng, Dingguo Huang, Weiqi Chen, Zijing Huang

    Laser photocoagulation remains the most common treatment for peripheral retinal degeneration. However, potential side effects, particularly inflammation and gliosis, raise concerns about an increased risk of epiretinal membrane (ERM) formation. This study aims to further investigate the association between laser photocoagulation and ERM formation and identify associated risk factors. This retrospective study included patients who underwent retinal laser photocoagulation for peripheral retinal degeneration. Clinical data including medical history, ophthalmic examinations during follow-up, and details of the laser photocoagulation, were recorded. Binary regression analysis was used to assess risk factors for ERM formation, including age, ocular findings, and laser parameters. Among the 726 eyes, 32 eyes (4.41%) developed ERM during a follow-up period of 29.7 ± 17.2 months. Risk factors included older age (53.9 ± 11.1 vs. 36.6 ± 17.3 years, P < 0.001), presence of lattice degeneration (62.5% vs. 40.3%, P < 0.001), greater number of laser spots (390.1 ± 171.9 vs. 284.8 ± 156.4, P < 0.001), higher total laser energy (22.5 ± 10.8J vs. 13.6 ± 11.9J, P < 0.001), wider extent of laser coverage (4.47 ± 3.38 vs. 3.08 ± 2.10 clock hours, P = 0.028), and shorter distance between the laser and the fovea (7.50 ± 1.72 vs. 8.36 ± 2.16 disc diameters, P = 0.017). Further regression analysis identified age (OR 1.071, 95% CI 1.040-1.102), number of laser spots (OR 1.003, 95% CI 1.001-1.005), and extent of laser coverage (OR 1.178, 95% CI 1.025-1.354) as independent risk factors for ERM development. Peripheral retinal laser photocoagulation does not significantly increase the incidence of ERM. However, careful control of the number and extent of laser applications may help minimize potential damage to the macula.


  • Cyclocryotherapy applied at the 3 o’clock and 9 o’clock positions combined with anti-VEGF injections for advanced neovascular glaucoma

    by Zijing Huang, Dingguo Huang, Jing Sheng Yi, Biyao Xie, Yifan Wang, Dezhi Zheng, Danqi Fang, Weiqi Chen

    Objective This study aimed to investigate the efficacy of cyclocryotherapy applied at the 3 o’clock and 9 o’clock positions in combination with intravitreal anti-vascular endothelial growth factor (VEGF) injections in patients with advanced neovascular glaucoma (NVG). Methods Medical records of patients diagnosed with NVG who underwent cyclocryotherapy at the 3 o’clock and 9 o’clock positions combined with intravitreal anti-VEGF injections between January 2021 and January 2023 were retrospectively reviewed. Baseline and follow-up data including intraocular pressure (IOP), best-corrected visual acuity, perioperative pain scores using numeric rating scale, intraocular cytokines levels, and surgical complications, were analyzed. A successful surgical outcome was defined as an IOP below 21 mmHg with at least a 30% reduction from baseline. Results A total of 20 eyes from 20 patients were included. Elevated levels of several inflammatory mediators and angiogenic cytokines were detected in aqueous and vitreous samples. Pain scores significantly decreased scores at one month postoperatively (0.5±0.9) compared to preoperative values (6.2±3.0) (P<0.001). At the 3-month follow up, the mean IOP was 26.4±15.9 mmHg, representing a 39.0% reduction from baseline (43.2±10.6 mmHg) (P=0.003). At the final follow-up visit (mean duration 13.3±4.5 months), the mean IOP was 26.6±15.2 mmHg, corresponding to a 38.4% reduction from baseline. No cases of anterior segment ischemia or phthisis bulbi were documented during the follow-up period. The surgical success rate was 55% at 3 months and 60% at the final follow-up. Conclusions Cyclocryotherapy applied at the 3 o’clock and 9 o’clock position combined with anti-VEGF treatment presents a potential treatment alternative for advanced NVG. Further research is needed to validate its long-term efficacy and safety profile.


  • Refractive outcomes following simultaneous silicone oil removal and ciliary sulcus intraocular lens implantation

    by Dezhi Zheng, Zijing Huang, Zhiying Chen, Dingguo Huang, Weiqi Chen

    Purpose: This study aimed to assess the refractive outcomes following the combined intervention of silicon oil (SO) removal and ciliary sulcus intraocular lens (IOL) implantation in aphakic eyes after phacovitrectomy. Methods: A retrospective examination of medical records from patients who underwent a combined procedure of SO removal and ciliary sulcus IOL implantation from 2019 to 2022 was performed. The primary outcomes of interest included uncorrected distance visual acuity (UDVA), predictive error (PE) and mean absolute predictive error (MAE). Subgroup analyses were performed to compare outcomes between patients with and without intraoperative posterior capsulotomy. Results: The cohort comprised 40 eyes from 40 patients, with a mean duration of SO tamponade of 5.17 ± 1.48 months. A significant improvement in UDVA was observed from 1.58 ± 0.31 logMAR to 0.99 ± 0.31 logMAR one month postoperatively ( P  < 0.01). The PE was −0.73 ± 0.86 diopters (D), and the MAE was 0.90 ± 0.67 D, with 37.50% and 57.50% of cases achieving PE within ±0.5 D and ±1.0 D, respectively. No significant differences in UDVA, PE, or MAE were found between the capsulotomy and non-capsulotomy subgroups (all P  > 0.05). However, a lower proportion of eyes in the capsulotomy group achieved PE within ±1.0 D compared to the non-capsulotomy group one month postoperatively (38.90% vs. 72.70%, P  = 0.03). Conclusions: The combined procedure of SO removal and sulcus IOL implantation resulted in a mild myopic shift in postoperative refraction. Intraoperative posterior capsulotomy seems to increase the lability of postoperative refractive outcomes.


  • Evaluation of combined epiretinal membrane removal with intravitreal triamcinolone injection utilizing ectopic inner foveal layer staging scheme

    by De-Zhi Zheng, Hong-Jie Lin, Gui-Hua Zhang, Ding-Guo Huang, Zi-Jing Huang, Wei-Qi Chen

    Objective To investigate the macular morphological and visual outcomes of combined idiopathic epiretinal membrane (iERM) removal with triamcinolone acetonide (TA) injection based on consideration of the ectopic inner foveal layer (EIFL) staging scheme. Methods Retrospective case–control study. The clinical data of 84 eyes of 84 patients who underwent vitrectomy for iERM between 2018 and 2022 were reviewed. The enrolled subjects were divided into the TA and non-TA groups. Fifty-one eyes received intravitreal TA injection following vitrectomy and ERM peeling (TA group), and 33 were only treated by standard vitrectomy and ERM peeling (non-TA group). Preoperative and postoperative EIFL stages, central foveal thickness (CFT), and best-corrected visual acuity (BCVA) were compared between both groups. Results After a mean follow-up of 7.69 ± 3.68 months, both groups exhibited significant improvement in EIFL stages (P < 0.01), with no discernible advantage observed in the TA group. The TA and non-TA groups demonstrated improvement in the EIFL stages in 56.86 and 63.64% of eyes, respectively (P = 0.43). The CFT and BCVA significantly improved in both groups at the final visit (P < 0.01). However, CFT in the non-TA group displayed a more significant reduction during the follow-up (P < 0.03). Subgroup analysis revealed no significant differences in postoperative CFT and BCVA between the two groups in cases with or without continuous EIFL (P > 0.10). Conclusion Our findings indicate that combined intravitreal TA injection following ERM removal conferred no significant benefits in alleviating macular thickening or improving visual acuity in iERM.


  • Open Access

    Subthreshold micropulse laser therapy for early postoperative macular thickening following surgical removal of epiretinal membrane

    by Hongjie Lin, Zijing Huang, Dingguo Huang, Dezhi Zheng, Peimin Lin, Yangxuan Lin, Weiqi Chen

    Background: This study aimed to investigate the functional and anatomical outcomes of subthreshold micropulse laser (SMPL) therapy in eyes with early postoperative macular thickening after idiopathic epiretinal membrane (iERM) removal.Methods: This was a prospective and interventional study. Forty-eight eyes from 48 patients with macular edema at 1 month after iERM removal were randomly divided into two groups. Patients in the SMPL group (n = 24) received SMPL therapy while no special intervention was used for the observation group (n = 24). Baseline demographic data and clinical findings before and at 1 and 3 months after SMPL treatment or observation, including best-corrected visual acuity (BCVA) and the changes in central subfield thickness (CST) and average macular thickness (AMT), were analyzed.Results: An improvement in BCVA with a decrease in CST and AMT from baseline to the 3-month follow-ups were observed in both SMPL and observation groups. No significant difference in BCVA was observed between the SMPL group and observation group either in the 1-month (0.26 [0.15, 0.52] vs. 0.26 [0.15, 0.39],P = 0.852) or the 3-month (0.15 [0.10, 0.30] vs. 0.23 [0.15, 0.30],P = 0.329) follow-up. There was a greater reduction in CST in the SMPL group versus observation group between baseline and the 3-month follow-up (-77.8 ± 72.3 μm vs. -45.0 ± 46.9 μm,P = 0.049). The alteration in AMT did not differ between the two groups in either 1-month (-16.5 ± 20.1 μm vs. -19.7 ± 16.3 μm,P = 0.547) or 3-month (-36.9 ± 26.9 μm vs. -34.0 ± 20.1 μm,P = 0.678) follow-up.Conclusions: SMPL therapy led to a significant decrease in CST at the 3-month follow-up while did not significantly improve the visual acuity in patients with postoperative macular thickening following iERM surgery.Trial registration: The study was registered on Aug 27, 2020 (Trial Registration Number: ChiCTR 2000037227).


  • Open Access

    Preoperative Intravitreal Conbercept Injection Reduced Both Angiogenic and Inflammatory Cytokines in Patients With Proliferative Diabetic Retinopathy

    by Zijing Huang, Li Jia Chen, Dingguo Huang, Jingsheng Yi, Zhiying Chen, Peimin Lin, Yifan Wang, Jianlong Zheng, Weiqi Chen

    Aims: To investigate the impact of intravitreal injection of conbercept, a recombinant fusion protein with decoy receptors for the vascular endothelial growth factor (VEGF) family, on intraocular concentrations of angiogenic and inflammatory mediators in patients with proliferative diabetic retinopathy (PDR), analyzed its potential impact on surgical outcomes.Methods: Forty eyes from 40 patients with PDR were included in this prospective study. Patients received intravitreal injection of conbercept followed by vitrectomy or phacovitrectomy in 1 week. Aqueous humor samples were collected before and 1 week after the conbercept injection. The concentrations of angiogenic and inflammatory cytokines and chemokines were measured by flow cytometry. Follow‐up clinical data were collected and analyzed.Results: Intravitreal conbercept injection significantly decreased aqueous concentrations of VEGF (325.5 (baseline) versus 22.3 pg/mL (postinjection), p < 0.0001), PlGF (39.5 versus 24.5 pg/mL, p < 0.0001), and PDGF‐A (54.1 versus 47.0 pg/mL, p = 0.0016), while no impact on bFGF levels. For inflammatory mediators, the concentration of TNF‐α (0.79 versus 0.45 pg/mL, p = 0.0004) and IL‐8 (180.6 versus 86 pg/mL, p < 0.0001) were decreased, while IL‐6 (184.1 versus 333.7 pg/mL, p = 0.0003) and IL‐10 (1.1 versus 1.5 pg/mL, p = 0.0032) were increased. No significant changes in IFN‐γ or MCP‐1 were detected. Three months after surgery, the mean best‐corrected visual acuity improved from a baseline of 1.8 ± 0.1 logMAR to 0.7 ± 0.1 logMAR (p < 0.0001), with 36 eyes (90%) achieving an improvement of visual function.Conclusions: Intravitreal conbercept injection presents dual effects of antiangiogenesis and anti‐inflammation and can be served as an adjuvant treatment to vitrectomy for PDR patients.